0001140361-16-089614.txt : 20161214 0001140361-16-089614.hdr.sgml : 20161214 20161214132128 ACCESSION NUMBER: 0001140361-16-089614 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161214 DATE AS OF CHANGE: 20161214 EFFECTIVENESS DATE: 20161214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioIQ, Inc. CENTRAL INDEX KEY: 0001530880 IRS NUMBER: 453328889 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-276257 FILM NUMBER: 162050743 BUSINESS ADDRESS: STREET 1: 1222 STATE STREET STREET 2: SUITE 200 CITY: SANTA BARBARA STATE: CA ZIP: 93101 BUSINESS PHONE: (805) 275-4004 MAIL ADDRESS: STREET 1: 1222 STATE STREET STREET 2: SUITE 200 CITY: SANTA BARBARA STATE: CA ZIP: 93101 D 1 primary_doc.xml X0707 D LIVE 0001530880 BioIQ, Inc. 1222 STATE STREET SUITE 200 Santa Barbara CA CALIFORNIA 93101 805-504-8586 DELAWARE None None Corporation true 2011 Justin Bellante 1222 State Street Suite 200 Santa Barbara CA CALIFORNIA 93101 Executive Officer Director Promoter Brent Peus c/o 1222 State Street Suite 200 Santa Barbara CA CALIFORNIA 93101 Executive Officer Jeff Closs c/o 1222 State Street Suite 200 Santa Barbara CA CALIFORNIA 93101 Director Brandon Cady c/o 1222 State Street Suite 200 Santa Barbara CA CALIFORNIA 93101 Director Kathleen Shanahan c/o 1222 State Street Suite 200 Santa Barbara CA CALIFORNIA 93101 Director Patrick Cua c/o 1222 State Street Suite 200 Santa Barbara CA CALIFORNIA 93101 Director Andrew Midler c/o 1222 State Street Suite 200 Santa Barbara CA CALIFORNIA 93101 Director Other Decline to Disclose 06b false 2016-08-31 false true true false 0 8399998 7067331 1332667 Series F Financing has concluded. The balance of Preferred Series F shares will be held in reserve. false 21 0 0 0 false BioIQ, Inc. Brent Peus /s/ Brent Peus Chief Financial Officer 2016-05-10